Ravulizumab

Red

Brand Name(s):Ultomiris

Indication:Paroxysmal nocturnal haemoglobinuria (PNH)- adults

Rationale:1,2,3

Considered:Aug-19

Review Date:Jun-26

Comments:
NICE TA698 recommend ravulizumab as an option for treating paroxysmal nocturnal haemoglobinuria in adults with haemolysis with clinical symptoms suggesting high disease activity, or whose disease is clinically stable after having eculizumab for at least 6 months.